Your SlideShare is downloading. ×
0
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
176482 633754879714110000
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

176482 633754879714110000

188

Published on

National Action Plan for a Flu Pandemic

National Action Plan for a Flu Pandemic

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
188
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Project Charter • Project: The Establishment of a National Pandemic Action Plan for Influenza in the US. • Organization: Center for Disease Control • Target Completion date: December 2013 • Team Members: Mohamed Sidi Haiba and Louai El Meqbeli • Scope: The project will analyze the flaws of the existing process and propose alternative solutions to improve it.
  • 2. Project Charter Cont’d Stakeholders: • Physicians • Patients • Healthcare Providers • Employers • General Population • Government
  • 3. Project Charter – Objectives The Stated Goal: Increasing the supply and capacity of delivery of influenza vaccines The Strategies Identified: • Developing an immunization policy to increase the demand for seasonal vaccines by an average rate of 10% a year. • Increasing influenza vaccine production capacity accordingly. • Promoting research and development for new influenza vaccines
  • 4. Project Charter – Objectives Developing an immunization policy to increase demand for seasonal vaccines • Map the landscape • Estimate the disease burden • Develop regional plans of action and mobilize resources • Encourage international coordination between between countries and regions of the world
  • 5. Project Charter – Objectives Increasing influenza vaccine production capacity The three most valuable options identified by WHO experts Include: 1.continuing to promote seasonal influenza vaccine programmers, 5. supporting the industry to sustain production capacity beyond seasonal demand and 7. enabling some vaccine production facilities to change, at the onset of a pandemic, from producing inactivated vaccines to live attenuated vaccines.
  • 6. Project Charter – Objectives Promote research and development for new influenza vaccines Develop more effective influenza vaccines using new technologies. The ideal product profile is a vaccine which is: • safe and highly protective, preferably in all target groups, including infants, the elderly, pregnant women and immuno-suppressed individuals; • is easily and economically produced on a large scale; • is effective – preferably with a low dose of antigen; • is delivered, ideally, as a single dose
  • 7. Deployment Model Need Drivers CTQs Requirements Seasonal clinic Mobile Staff Improving the uptake of the influenza vaccines in the USA Media Enhance efficacy of campaign exiting vaccines and promote research for new ones Client recall reminder Providers feedback
  • 8. Mapping the existing process • Influenza Vaccine Doses distributed, United States 1964-2004. • % of persons aged ≥ 65 years who reported receiving Vaccination during the preceding 12 months, by race/ethnicity and survey year- national health interview survey, US 1989-2003. • % of persons aged 18-64 years who reported receiving influenza vaccination during the preceding 12 months, by race/ethnicity and survey year-national health interview survey, US 1989-2003. • Cumulative Monthly Influenza Vaccine Distribution for 1999, 2000, 2001, 2002, 2003-04, 2004-05. • % of influenza Vaccination by month, selected priority US populations, BRFSS 2004-05
  • 9. Determining the process variation To achieve this objective, one needs first to • examine the nature of the cause effects we are dealing with. • Are they common or special? • Given the data we have so far and the fact that our strategic approach is already known (improvement process), we know in advance that our variation type is stable and our cause effects are common.
  • 10. Identifying the root causes Based on the analysis of existing data we have identified several root causes, but the most important are: • Lack of education • Difficulties to access • Cost • Vaccine shortages • Gaps in R & D
  • 11. Proposed Solutions • Creating a robust and effective supply and delivery chain. • Developing a stockpiles of vaccines. • Resolving policy regulatory and coordination • Broaden access to vaccination e.g. workplace, community, pharmacies, seasonal clinics. • Raise the awareness of the public about the importance of vaccination (public information). • Mandate employers to offer vaccine free of charge or at an affordable cost (on site if possible). • Extend the requirement to public schools, nursing homes, kindergarten.
  • 12. Cont’d Solutions • Enhance demand among vulnerable segments of the population “elderly people, infants, pregnant women, children etc…” • Extend the critical period of coverage beyond December. • Link Influenza vaccination with the delivery of other vaccination among adolescents.
  • 13. Implementation Process Enhancement year 1 year 2 year 3 year 4 Strategies 10% 20% 30% 40% Client reminder/recall 15% 30% 45% 60% Multicomponent education 10% 20% 30% 40% Cost reduction 20% 40% 60% 80% Reducing difficulty to access 10% 20% 30% 40% Provider reminder /recall
  • 14. Summary The availability of data is a crucial step in statistical analysis. Although, we Were unable to obtain/collect all the data we needed, we had enough to kick start our mapping process and devise some of our proposed solutions. The three most valuable proposals identified by WHO experts include: • continuing to promote seasonal influenza vaccine programmers, • supporting the industry to sustain production capacity beyond seasonal demand and • enabling some vaccine production facilities to change, at the onset of a pandemic, from producing inactivated vaccines to live attenuated vaccines. Finally, in order for the process to be efficiently implemented and to take root In the long run, the improvements achieved need to be maintained and Ultimately institutionalized. In this regard the institution of a process control level is of great importance.
  • 15. Critique of the sources: • Statistical Thinking (improving business performance) by R. Hoerl and R Snee • Department of Health & Human Services HHS • www.who.org • Http://www.isixsigma.com/library/content/c001211a.asp. • www.dtic.mil/ndia/2003CMMI/Facemire.ppt
  • 16. Thank you for your attention! Now do you have any Questions ?

×